Solicitation of Nominations for Appointment to the Healthcare Infection Control Practices Advisory Committee (HICPAC), 14921 [2021-05785]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 52 / Friday, March 19, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–05766 Filed 3–18–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Healthcare
Infection Control Practices Advisory
Committee (HICPAC)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
HICPAC. The HICPAC consists of 14
experts in fields including but not
limited to, infectious diseases, infection
prevention, healthcare epidemiology,
nursing, clinical microbiology, surgery,
hospitalist medicine, internal medicine,
epidemiology, health policy, health
services research, public health, and
related medical fields. Nominations are
being sought for individuals who have
expertise and qualifications necessary to
contribute to the accomplishments of
the committee’s objectives. Nominees
will be selected based on expertise in
the fields of infectious diseases,
infection prevention, healthcare
epidemiology, nursing, environmental
and clinical microbiology, surgery,
internal medicine, and public health.
Federal employees will not be
considered for membership. Members
may be invited to serve for four-year
terms. Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of HICPAC
objectives https://www.cdc.gov/hicpac/.
DATES: Nominations for membership on
the HICPAC must be received no later
than September 17, 2021. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to HICPAC, Division of
Healthcare Quality Promotion (DHQP),
National Center for Emerging Zoonotic
Infectious Diseases (NCEZID), CDC, l600
Clifton Road NE, Mailstop H16–3,
Atlanta, Georgia 30329–4027, emailed
(recommended) to hicpac@cdc.gov, or
faxed to (404) 639–4043.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, MPH, HICPAC, DHQP,
NCEZID, CDC, l600 Clifton Road, NE,
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:13 Mar 18, 2021
Jkt 253001
14921
Mailstop H16–3, Atlanta, Georgia
30329–4027; hicpac@cdc.gov.
Prevention and the Agency for Toxic
Substances and Disease Registry.
The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for HICPAC membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2022, or as
soon as the HHS selection process is
completed. Please note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. Candidates should
submit the following items:
■ Current curriculum vitae,
including complete contact information
(telephone numbers, mailing address,
email address); and
■ At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
[FR Doc. 2021–05785 Filed 3–18–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–1238; Docket No. CDC–2021–
0029]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled, The EDN Tuberculosis Follow-Up
Worksheet for Newly-Arrived Persons
with Overseas Tuberculosis
Classifications. This TB follow-up
worksheet intends to capture domestic
TB examination data for persons
arriving to the U.S. with overseas TB
classifications.
DATES: CDC must receive written
comments on or before May 18, 2021.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0029 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
SUMMARY:
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 86, Number 52 (Friday, March 19, 2021)]
[Notices]
[Page 14921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05785]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Healthcare
Infection Control Practices Advisory Committee (HICPAC)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the HICPAC. The HICPAC consists
of 14 experts in fields including but not limited to, infectious
diseases, infection prevention, healthcare epidemiology, nursing,
clinical microbiology, surgery, hospitalist medicine, internal
medicine, epidemiology, health policy, health services research, public
health, and related medical fields. Nominations are being sought for
individuals who have expertise and qualifications necessary to
contribute to the accomplishments of the committee's objectives.
Nominees will be selected based on expertise in the fields of
infectious diseases, infection prevention, healthcare epidemiology,
nursing, environmental and clinical microbiology, surgery, internal
medicine, and public health. Federal employees will not be considered
for membership. Members may be invited to serve for four-year terms.
Selection of members is based on candidates' qualifications to
contribute to the accomplishment of HICPAC objectives https://www.cdc.gov/hicpac/.
DATES: Nominations for membership on the HICPAC must be received no
later than September 17, 2021. Packages received after this time will
not be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to HICPAC, Division of
Healthcare Quality Promotion (DHQP), National Center for Emerging
Zoonotic Infectious Diseases (NCEZID), CDC, l600 Clifton Road NE,
Mailstop H16-3, Atlanta, Georgia 30329-4027, emailed (recommended) to
[email protected], or faxed to (404) 639-4043.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, MPH, HICPAC, DHQP,
NCEZID, CDC, l600 Clifton Road, NE, Mailstop H16-3, Atlanta, Georgia
30329-4027; [email protected].
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens, and cannot be full-time employees of
the U.S. Government. Current participation on federal workgroups or
prior experience serving on a federal advisory committee does not
disqualify a candidate; however, HHS policy is to avoid excessive
individual service on advisory committees and multiple committee
memberships. Committee members are Special Government Employees (SGEs),
requiring the filing of financial disclosure reports at the beginning
and annually during their terms. CDC reviews potential candidates for
HICPAC membership each year and provides a slate of nominees for
consideration to the Secretary of HHS for final selection. HHS notifies
selected candidates of their appointment near the start of the term in
July 2022, or as soon as the HHS selection process is completed. Please
note that the need for different expertise varies from year to year and
a candidate who is not selected in one year may be reconsidered in a
subsequent year. Candidates should submit the following items:
[squf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address); and
[squf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-05785 Filed 3-18-21; 8:45 am]
BILLING CODE 4163-18-P
